Advertisement

Topics

Genomic Profiling Systems Company Profile

11:08 EST 16th December 2018 | BioPortfolio

Genomic Profiling Systems, Inc. (GPS) is developing pioneering products to address the significant need for rapid microbial and molecular analysis in industrial microbiology and healthcare. GPS's suite of technologies for detecting microbes and molecules provides tests that are rapid, quantitative and ultra-sensitive while being simple, user-friendly, and cost-effective to implement.

Location

One Oak Park Drive, 2nd Floor
Bedford
Massachusetts
01730
United States of America

Contact

Phone: 781-271-1444
Fax: 781-271-9905
Email: info@genprosys.com


News Articles [877 Associated News Articles listed on BioPortfolio]

Genomic profiling offers hope for rare cancer treatments

A clinical trial led by Walter and Eliza Hall Institute of Medical Research in Australia has demonstrated that genomic profiling...Read More... The post Genomic profiling offers hope for rare cancer t...

Roche launches FoundationOne CDx genomic profiling assay in Singapore

FoundationOne CDx, which is Foundation Medicine’s comprehensive companion diagnostic test, will support clinicians in better decision-making. It provides clear and in-depth report that presents the ...

Utility of Genomic Profiling in Treating Advanced Sarcomas

Molecular profiling may be particularly useful in guiding therapy of sarcoma with an unclear diagnosis or rare subtype. JCO Precision Oncology

Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer

Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancerGenomic and expression profiling reveal molecular heterogeneity of diss...

Comprehensive genomic profiling aids in the identification of personalised therapeutic options

Findings from a recent study demonstrate that comprehensive genetic profiling (CGP) is a useful tool in directing patient care, including the identification of targeted therapies and enrollment in cli...

Press Release: Roche announces global availability of blood-based genomic profiling test, FoundationOne Liquid

F. Hoffmann-La Roche Ltd / Roche announces global availability of blood-based genomic profiling test, FoundationOne Liquid . Processed and transmitted by West Corporation. The issuer is solely res...

FDA approves pan-tumour genomic profiling assay

A reassessment of DNA-immunoprecipitation-based genomic profiling

PubMed Articles [1967 Associated PubMed Articles listed on BioPortfolio]

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced non-small cell lung cancer.

Genomic profiling informs selection of matched targeted therapies as part of routine clinical care in non-small cell lung cancer (NSCLC). Tissue biopsy is the gold standard; however, genomic profiling...

Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy.

Genomic profiling for personalized targeted therapy has become standard of care. We report the success of genomic profiling of non-small cell lung cancer (NSCLC) obtained by trans-thoracic needle biop...

Return of secondary findings in genomic sequencing: Military implications.

Genomic sequencing has become a widely used tool in clinical and research settings in both civilian and military healthcare systems.

Analytical validation of a hybrid capture-based next-generation sequencing clinical assay for genomic profiling of cell-free circulating tumor DNA.

Genomic profiling of circulating tumor DNA derived from cell-free DNA (cfDNA) in blood can provide a non-invasive method for the detection of genomic biomarkers to guide clinical decision-making for c...

Low clinical adoption of tumor genomic profiling: cause for concern?

Clinical Trials [1776 Associated Clinical Trials listed on BioPortfolio]

Advanced Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling

The objective of this protocol is to characterize advanced cancer patients' responses to learning their secondary findings arising from tumor genomic profiling, and the process and outcome...

Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer

The primary objective is to examine the impact on progression-free survival of targeted therapy for breast cancer suggested by proteomic and genomic profiling.

Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

Overall survival rates for patients with metastatic NSCLC are poor utilizing conventional cytotoxic chemotherapy approaches. However, a subset of patients harbor genomic driver mutations, ...

Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

With the increased availability of next-generation sequencing, oncologists are starting to incorporate genomic profiling into routine care of cancer patients. If a genomic alteration is id...

Genomic Testing and Resulting Medical Decisions

There is no evidence available about which molecular profiling methods are currently used for cancer patients in Austrian clinical practice. The construction of the registry proposed as a ...

Companies [1716 Associated Companies listed on BioPortfolio]

Genomic Profiling Systems

Genomic Profiling Systems, Inc. (GPS) is developing pioneering products to address the significant need for rapid microbial and molecular analysis in industrial microbiology and healthcare. GPS's suit...

Genomic Health

Genomic Health gives cancer patients and physicians insight needed to help make quality treatment decisions. GenomicHealth.com is designed to help patients, caregivers and healthcare professionals und...

KEW, Inc.

KEW, Inc. is a privately-held comprehensive genomic profiling company with headquarters in Cambridge, MA, USA., dedicated to revolutionizing cancer care by providing therapeutic o...

Genomic Technologies

Genomic Technologies utilizes its proprietary instrument control software and well proven mechanical systems for rapid development of synthesis platforms ranging from analytical to preparative scale s...

Genomic Systems

Genomic Systems is a privately held start-up biotechnology company that is in-licensing, developing and commercializing novel targeted therapeutics that address serious unmet medi...

More Information about "Genomic Profiling Systems" on BioPortfolio

We have published hundreds of Genomic Profiling Systems news stories on BioPortfolio along with dozens of Genomic Profiling Systems Clinical Trials and PubMed Articles about Genomic Profiling Systems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genomic Profiling Systems Companies in our database. You can also find out about relevant Genomic Profiling Systems Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Microbiology
Microbiology (from Greek μῑκρος, mīkros, "small"; βίος, bios, "life"; and -λογία, -logia) is the study of microscopic organisms, either unicellular (singl...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record